All Pharma News
Lilly Completes Acquisition of Sigilon Therapeutics

Lilly Completes Acquisition of Sigilon Therapeutics
PR NEWSWIRE
14 Aug 2023
Share Share
Lilly’s yes-no-yes journey to acquiring Sigilon

Lilly’s yes-no-yes journey to acquiring Sigilon
Annalee Armstrong FIERCE BIOTECH
13 Jul 2023
Share Share
Lilly buys diabetes cell therapy partner Sigilon for $35M

Lilly buys diabetes cell therapy partner Sigilon for $35M
Nick Paul Taylor FIERCE BIOTECH
30 Jun 2023
Share Share
Lilly to Acquire Diabetes Cell Therapy Company Sigilon Therapeutics

Lilly to Acquire Diabetes Cell Therapy Company Sigilon Therapeutics
CONTRACT PHARMA
29 Jun 2023
Share Share
Sigilon Announces Reverse Stock Split of Common Stock

Sigilon Announces Reverse Stock Split of Common Stock
GLOBENEWSWIRE
22 May 2023
Share Share
Sigilon Therapeutics Reports1Q 2023 FYR and Business Highlights

Sigilon Therapeutics Reports1Q 2023 FYR and Business Highlights
GLOBENEWSWIRE
09 May 2023
Share Share
Sigilon Therapeutics to Present at the Needham Virtual Healthcare Conference

Sigilon Therapeutics to Present at the Needham Virtual Healthcare Conference
GLOBENEWSWIRE
18 Apr 2023
Share Share
Sigilon focuses on type 1 diabetes, reduces spend on MPS-1 after letting CMO go

Sigilon focuses on type 1 diabetes, reduces spend on MPS-1 after letting CMO go
Kyle LaHucik ENDPTS
15 Mar 2023
Share Share
Sigilon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results

Sigilon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
GLOBENEWSWIRE
14 Mar 2023
Share Share
Sigilon Therapeutics Reports 3Q 2022 Financial Results and Business Highlights

Sigilon Therapeutics Reports 3Q 2022 Financial Results and Business Highlights
GLOBENEWSWIRE
10 Nov 2022
Share Share